stella
beta
Fabhalta Capsules Specified Drug-use Survey β Stella
Home
/
C3 Glomerulopathy
/
View on ClinicalTrials.gov
Recruiting
Back to C3 Glomerulopathy trials
Trial locations
(26 sites)
Japan
Novartis Investigative Site, Nagoya, Aichi-ken
Novartis Investigative Site, Toyoake, Aichi-ken
Novartis Investigative Site, Hirosaki, Aomori
Novartis Investigative Site, Chiba, Chiba
Novartis Investigative Site, Kitakyushu, Fukuoka
Novartis Investigative Site, Sapporo, Hokkaido
Novartis Investigative Site, Sapporo, Hokkaido
Novartis Investigative Site, Tsukuba, Ibaraki
Novartis Investigative Site, Komatsu, Ishikawa-ken
Novartis Investigative Site, Tsu, Mie-ken
Novartis Investigative Site, Nagasaki, Nagasaki
Novartis Investigative Site, Shimajiri-Gun, Okinawa
Novartis Investigative Site, Suita, Osaka
Novartis Investigative Site, Takatsuki, Osaka
Novartis Investigative Site, Kusatsu, Shiga
Novartis Investigative Site, Ohtsu, Shiga
Novartis Investigative Site, Shimotsuga Gun, Tochigi
Novartis Investigative Site, Tokushima, Tokushima
Novartis Investigative Site, Bunkyo-ku, Tokyo
Novartis Investigative Site, FuchΕ«, Tokyo
Novartis Investigative Site, Nakano City, Tokyo
Novartis Investigative Site, Shinjuku Ku, Tokyo
Novartis Investigative Site, Yosa, Yosa
Novartis Investigative Site, Hiroshima
Novartis Investigative Site, Nara
Novartis Investigative Site, Wakayama